Brenda Sandmaier, MD
Enriched profileProfessor and Deputy Director, Translational Science and Therapeutics Division · Fred Hutchinson Cancer Center
Brenda Sandmaier is Professor and Deputy Director, Translational Science and Therapeutics Division at Fred Hutchinson Cancer Center. OpenAlex indexes 670 publications with 36,879 citations (h-index 92); ClinicalTrials.gov lists 22 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Hematology / Oncology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 31 Aug 2026
Brenda Sandmaier is Professor and Deputy Director, Translational Science and Therapeutics Division at Fred Hutchinson Cancer Center. The public record shows 670 publications with 36,879 citations (h-index 92), centered on Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research. It also documents an investigator role on 22 registered clinical trials, industry payments reported by 2 companies, 11 NIH-funded awards (1990–2025).
- Most recent indexed publication: 2026 · Blood
- Top research focus: Hematopoietic Stem Cell Transplantation
- 22 registered trials on ClinicalTrials.gov
- Open Payments reporting from 2 companies
Generated from the cited public record · current as of 31 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 50 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 308.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 31 Aug 2026
Listed as an investigator on 22 registered studies on ClinicalTrials.gov. The most recent:
- Yttrium-90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk AML, ALL, or MDS
Sponsor: Fred Hutchinson Cancer Center
- Clofarabine and Low-Dose Total-Body Irradiation in Treating Patients With Acute Myeloid Leukemia Undergoing Donor Peripheral Blood Stem Cell Transplant
Sponsor: Fred Hutchinson Cancer Center
Industry payments
Updated 31 Aug 2026
2 companies reported payments to CMS in program years 2021–2022. These are public disclosures, not judgments. The latest:
- Apellis Pharmaceuticals, Inc.Program year20221 payment
- JAZZ PHARMACEUTICALS INC.Program year20211 payment
NIH funding
Updated 31 Aug 2026
11 NIH research awards on record, funded 1990–2025 per NIH RePORTER. The latest:
- Preventing Relapse After Non-myeloablative Stem Cell Transplantation: The Final Challenge
Fred Hutchinson Cancer Center
FY2025$2,074,913P01CA078902 - Project 2: Alpha-Emitter Radioimmunotherapy-Based Allografting to Cure Acute Leukemia and Myelodysplastic Syndrome
Fred Hutchinson Cancer Center
FY2025$283,800P01CA078902
Congress activity
Updated 31 Aug 2026
32 congress contributions (2006–2024) across ASCO, ASH per OpenAlex. The most recent:
- Allogeneic Hematopoietic Cell Transplantation (HCT) for Adults with Acute Myeloid Leukemia Older Than Age 60
ASH Annual Meeting
ASH2024Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 31 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Comparative In Vitro Evaluation of Anti-HIV Immunotoxin, Antibody-Drug Conjugate, and Radioimmunoconjugate Targeted by the Same Antibody.
Antibodies (Basel, Switzerland)
Article2026 - Respiratory Virus Infections and Pulmonary Impairment After Allogeneic Hematopoietic Cell Transplantation.
The Journal of infectious diseases
Article2026 - Pretargeted Anti-CD20 Radioimmunotherapy with scFv Fusion Protein Safely Combines with BEAM and ASCT in Patients with High-risk B-cell Lymphomas.
Molecular cancer therapeutics
Clinical Trial2025
Most-cited works
by citation count (OpenAlex)- 01
- 02
- 03Defining the Intensity of Conditioning Regimens: Working Definitions1,804 citations2009
- 04Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation1,480 citations2010
- 05
Network
Updated 31 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 31 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- LinkedIn
linkedin.com/in/brenda-sandmaier-6b173639
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Brenda-Sandmaier-2
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - Doximity
doximity.com/pub/brenda-sandmaier-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
fredhutch.org/en/news/center-news/2022/04/sandmaier-astct-presidency.html
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗ - LinkedIn
LinkedIn profile: "Brenda Sandmaier - Professor and Deputy Director of the Translational Science and Therapeutics Division"
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - ResearchGate
ResearchGate profile: "Professor (Full) and Deputy Director, Fred Hutch Cancer Center, Seattle"
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 31 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗
- MD
University of Alberta
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗ - BSc
Genetics, University of Alberta
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗
Secondary affiliations
appointments beyond the home institution- Professor
Division of Hematology and Oncology, University of Washington School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗ - Member
Immunotherapy Integrated Research Center (IIRC), Fred Hutch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗ - Affiliate Investigator
Clinical Research Division, Fred Hutch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →globenewswire.com ↗
- News feature: "ASTCT Names Brenda Sandmaier President"
ASH Clinical News (American Society of Hematology)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ashpublications.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
David Maloney, MD, PhD
Fred Hutchinson Cancer Center
Lawrence Fong, MD
Fred Hutchinson Cancer Center
Michael Boeckh, MD
Fred Hutchinson Cancer Center